To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
Fig 1
Key actor groups in the innovation system of antimalarial therapies.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Key actor groups in the innovation system of antimalarial therapies.